Analyst Reco.

06-11 Rothschild & Co Redburn Upgrades CME Group to Buy From Neutral, Adjusts PT to $323 From $316 MT
06-03 Autonomous Research Adjusts Price Target on CME to $328 From $326, Maintains Outperform Rating MT
04-29 Autonomous Research Adjusts Price Target on CME Group to $326 From $344, Maintains Outperform Rating MT
04-27 Rothschild & Co Redburn Adjusts Price Target on CME Group to $316 From $340, Maintains Neutral Rating MT
04-23 CME Sees Record Volumes Offset by Pricing Pressure; Data Services Momentum Remains Strong, RBC Says MT
04-23 CME Group Viewed as Strongest Liquidity Venue in Current Market, Morgan Stanley Says MT
04-23 Barclays Adjusts Price Target on CME Group to $316 From $343, Maintains Equalweight Rating MT
04-23 Deutsche Bank Lowers Price Target on CME Group to $322 From $342, Keeps Buy Rating MT
04-23 Goldman Sachs Adjusts Price Target on CME Group to $267 From $275, Maintains Sell Rating MT
04-23 Morgan Stanley Trims Price Target on CME Group to $353 From $362, Keeps Overweight Rating MT
04-23 JPMorgan Adjusts Price Target on CME to $273 From $271, Maintains Underweight Rating MT
04-23 TD Cowen Adjusts Price Target on CME to $323 From $340, Maintains Buy Rating MT
04-23 Barclays Adjusts Price Target on CME to $316 From $343, Maintains Equalweight Rating MT
04-16 JPMorgan Adjusts Price Target on CME Group to $271 From $266, Maintains Underweight Rating MT
04-15 Piper Sandler Adjusts Price Target on CME Group to $329 From $313, Maintains Overweight Rating MT
04-13 Rothschild & Co Redburn Adjusts CME Group Price Target to $340 From $347, Maintains Neutral Rating MT
04-09 Jefferies Adjusts Price Target on CME Group to $349 From $356, Maintains Buy Rating MT
04-09 TD Cowen Adjusts Price Target on CME to $340 From $328, Keeps Buy Rating MT
04-08 Barclays Adjusts Price Target on CME Group to $344 From $312, Maintains Equalweight Rating MT
04-07 Autonomous Research Adjusts Price Target on CME to $344 From $339, Maintains Outperform Rating MT
04-06 Raymond James Adjusts Price Target on CME Group to $320 From $310, Maintains Outperform Rating MT
03-16 Goldman Sachs Adjusts Price Target on CME to $275 From $266, Maintains Sell Rating MT
03-12 Rothschild & Co Redburn Adjusts Price Target on CME to $347 From $333, Maintains Neutral Rating MT
03-04 Argus Downgrades CME to Hold From Buy MT
03-02 Jefferies Adjusts Price Target on CME Group to $356 From $302, Maintains Buy Rating MT
No results match your criteria
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!